Big relief for cancer patients: Medicine prices may fall by up to 70% in India

Cancer patients in India could soon pay significantly less for certain expensive medicines as the Centre moves to cap trade margins on non-scheduled anti-cancer drugs at 30%. The government estimates that the decision could reduce some medicine prices by up to 70% and save patients around ₹2,500 crore annually.

According to government estimates, the decision could help patients save around ₹2,500 crore annually. The move comes days after the Supreme Court raised serious concerns over the pricing of cancer medicines, questioning how a drug supplied to retailers for ₹2,700 could carry an MRP of ₹27,000. The government is now working on implementing the revised pricing framework.

Read more: Nana Patekar dies of cardiac arrest: Warning signs to watch for and what to do | Exclusive

Why are cancer medicine prices so high in India?

One major reason........

© News9Live